Mercy BioAnalytics
Natick, US · Founded 2018 · 64 employees on LinkedIn · 7 known investors
Find your way into Mercy BioAnalytics
180 people in our graph share verified history with the Mercy BioAnalytics team — schools, employers, funds. One of them is your warm intro.
John Kimunlockedknows Paul Blavin · together at Harvard Business School (overlapped)
.png)
×11knows the team · via Harvard Business School
Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies. The company serves healthcare providers and patients seeking to improve cancer detection accuracy and timing.
Founders & leadership
Mercy BioAnalytics was founded in 2018 by Paul Blavin and Stanley Lapidus.
PB
Paul BlavininCo-Founder & Vice ChairmanPaul Blavin is co-founder and Vice Chairman of Mercy BioAnalytics, which develops diagnostic tests for early cancer detection. He co-founded the Blavin Scholars in 2003, a nonprofit supporting individuals with foster care or homelessness experience in pursuing post-secondary education.
SL
Stanley LapidusCo-founder
DM
Dawn Mattoon, PhDChief Executive Officer
JS
Joseph SedlakExecutive
Board
PM
Paul MeisterBoard director
SH
Sonja Hoel PerkinsBoard director
Investors · 7
Funding
SEC filings, press & company announcements$68.3M disclosed across 2 of 4 rounds · 2020–2025
- Undisclosed amountSeries BSep 2025Source ↗
- Undisclosed amountSeries AApr 2023Source ↗
- $41MraisedApr 2023 · 2 sourcesSource ↗
▶$27.3MraisedFeb 2021 · 57 investors · BiotechnologyRule 506(b)
▶$27.3MraisedFeb 2021 · 57 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul BlavinExecutive Officer, Director
- Joseph SedlakExecutive Officer, Director
- Stanley LapidusDirector
- Paul MeisterDirector
- Sonja Hoel PerkinsDirector
- Offering amount
- $27.3M
- Amount sold
- $27.3M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Mercy BioAnalytics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Mercy BioAnalytics do?
- Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies. The company serves healthcare providers and patients seeking to improve cancer detection accuracy and timing.
- Who founded Mercy BioAnalytics?
- Mercy BioAnalytics was founded by Paul Blavin, Stanley Lapidus in 2018.
- Who are Mercy BioAnalytics's investors?
- Mercy BioAnalytics's investors include Hatteras Venture Partners, iSelect Fund, Mindshift Capital, Novalis LifeSciences, Portfolia, Sozo Ventures, The Perkins Fund.
- How much funding has Mercy BioAnalytics raised?
- Mercy BioAnalytics has disclosed $68.3M raised across 2 of its 4 known rounds.
- Where is Mercy BioAnalytics headquartered?
- Mercy BioAnalytics is headquartered in Natick, US.